ILMN - Illumina, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
307.63
-2.22 (-0.72%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Previous Close309.85
Open307.10
Bid305.00 x 900
Ask311.18 x 1100
Day's Range307.10 - 313.19
52 Week Range261.61 - 372.61
Volume559,705
Avg. Volume948,849
Market Cap45.222B
Beta (3Y Monthly)1.34
PE Ratio (TTM)53.78
EPS (TTM)5.72
Earnings DateJul 29, 2019 - Aug 2, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est343.08
Trade prices are not sourced from all markets
  • Final trades: Illumina, Home Depot & Colgate
    CNBC Videos2 days ago

    Final trades: Illumina, Home Depot & Colgate

    The "Halftime Report" traders give their top stocks to watch for the second half.

  • Final Trades: Disney, Illumina, Impinj & Gold
    CNBC Videos11 days ago

    Final Trades: Disney, Illumina, Impinj & Gold

    The "Halftime Report" traders give their top stocks to watch for the second half

  • Financial Times2 days ago

    UK life science companies show signs of health

    The region, with eight research intensive universities, is home to a £13.6bn industry and 21 per cent of the total UK life science sector workforce, according to the Northern Health Science Alliance. Some are now showing signs of health. share price into the doldrums, this year is proving more positive for the pharmaceuticals company behind iron deficiency drug Feraccru.

  • Business Wire4 days ago

    Illumina Files Patent Infringement Suit Against BGI in Denmark

    Illumina, Inc. today announced that it has filed another patent infringement suit against one of BGI Group’s subsidiaries, BGI Europe A/S. Illumina filed suit in the Maritime & Commercial High Court of Denmark.

  • Is Illumina, Inc.'s (NASDAQ:ILMN) CEO Overpaid Relative To Its Peers?
    Simply Wall St.5 days ago

    Is Illumina, Inc.'s (NASDAQ:ILMN) CEO Overpaid Relative To Its Peers?

    Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift...

  • GILD vs. ILMN: Which Stock Is the Better Value Option?
    Zacks6 days ago

    GILD vs. ILMN: Which Stock Is the Better Value Option?

    GILD vs. ILMN: Which Stock Is the Better Value Option?

  • Here's Why You Should Invest in Illumina (ILMN) Stock Now
    Zacks6 days ago

    Here's Why You Should Invest in Illumina (ILMN) Stock Now

    Illumina (ILMN) has been gaining investor confidence on robust performance.

  • 3 Stocks to Buy and Hold for Decades
    Motley Fool10 days ago

    3 Stocks to Buy and Hold for Decades

    These companies focused on genetics, glamor, and gaming are worth considering for the long haul.

  • CNBC11 days ago

    Human lifespan could soon pass 100 years thanks to medical tech, says BofA

    One of the biggest investment opportunities over the next decade will be in companies working to delay human death, a market expected to be worth at least $600 billion by 2025, according to Bank of America analysts. One of the biggest investment opportunities over the next decade will be in companies working to delay human death, a market expected to be worth at least $600 billion by 2025, according to one of Wall Street's major investment banks.

  • Bloomberg11 days ago

    ‘App Store for DNA’ Fizzles as Health Startup Shifts Strategy

    Some testing firms are finding it works better when health-care providers are more directly involved. Helix, which launched in 2015 with $100 million from genome-sequencing giant Illumina Inc., had planned to sell tests directly through an “app store’’ for DNA. Instead, it’s now looking to partner with health-care providers.

  • PR Newswire11 days ago

    Population Health Study Goes Statewide As University Medical Center of Southern Nevada Serves As Host Site For Enrollment Of 25,000 More Nevadans

    LAS VEGAS, May 7, 2019 /PRNewswire/ -- The Healthy Nevada Project, a first-of-its-kind, community-based population health study combining genetic, clinical, environmental and social data, is expanding enrollment to Las Vegas. The Project aspires not only to offer genetic testing to every Nevadan interested in learning more about their health and genetic profile but ultimately, to develop and expand the Project for communities across the United States to drive positive health outcomes nationwide.

  • Is Illumina (ILMN) Outperforming Other Medical Stocks This Year?
    Zacks12 days ago

    Is Illumina (ILMN) Outperforming Other Medical Stocks This Year?

    Is (ILMN) Outperforming Other Medical Stocks This Year?

  • Markit12 days ago

    See what the IHS Markit Score report has to say about Illumina Inc.

    Illumina Inc NASDAQ/NGS:ILMNView full report here! Summary * ETFs holding this stock have seen outflows over the last one-month * Bearish sentiment is low * Economic output in this company's sector is expanding Bearish sentimentShort interest | PositiveShort interest is low for ILMN with fewer than 5% of shares on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Money flowETF/Index ownership | NegativeETF activity is negative. Over the last one-month, outflows of investor capital in ETFs holding ILMN totaled $5.28 billion. Additionally, the rate of outflows appears to be accelerating. Economic sentimentPMI by IHS Markit | PositiveAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is strong relative to the trend shown over the past year, and is accelerating. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to score@ihsmarkit.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.

  • Pacific Biosciences (PACB) Incurs Loss in Q1, Revenues Fall
    Zacks12 days ago

    Pacific Biosciences (PACB) Incurs Loss in Q1, Revenues Fall

    Pacific Biosciences' (PACB) segments see softness in Q1; merger with Illumina on track.

  • Where Will Illumina Be in 10 Years?
    Motley Fool14 days ago

    Where Will Illumina Be in 10 Years?

    The gene sequencing pioneer could face several scenarios in the future -- from very good to very bad.

  • 5 Top Stocks to Buy in May
    Motley Fool15 days ago

    5 Top Stocks to Buy in May

    Find out why this team of Motley Fool contributors believe these businesses are strong buys right now.

  • Business Wire17 days ago

    Illumina to Webcast Upcoming Investor Conference Presentation

    Illumina, Inc. (ILMN) today announced that its executives will be speaking at the following investor conference and invited investors to participate via webcast. The live webcast can be accessed in the Investor Relations section of Illumina's web site under the "company" tab at www.illumina.com. A replay of the presentation will be posted on Illumina’s web site after the event and will be available for at least 30 days following.

  • Buyback Stocks Badly Lag S&P 500 Amid Mounting Criticism
    Investopedia19 days ago

    Buyback Stocks Badly Lag S&P 500 Amid Mounting Criticism

    Companies that invested heavily in buybacks saw their shares rise just 7% in 12 months, versus a 13% gain for the S&P 500, per Goldman Sachs.

  • Thomson Reuters StreetEvents22 days ago

    Edited Transcript of ILMN earnings conference call or presentation 25-Apr-19 9:00pm GMT

    Q1 2019 Illumina Inc Earnings Call

  • Illumina (ILMN) Q1 Earnings Beat Estimates, Gross Margin Up
    Zacks23 days ago

    Illumina (ILMN) Q1 Earnings Beat Estimates, Gross Margin Up

    Illumina's (ILMN) NextSeq and MiSeq placements witness year-over-year growth, with the strength of the former being driven by solid demand for TSO500.

  • Benzinga23 days ago

    The Daily Biotech Pulse: Mixed Results For Merck's Keytruda In Stomach Cancer; Roche's Spark-Buy Delayed, Teva Recalls Hypertension Drug

    Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on April 25) Biohaven Pharmaceutical Holding Co Ltd (NYSE: BHVN ...

  • Illumina Inc (ILMN) Q1 2019 Earnings Call Transcript
    Motley Fool23 days ago

    Illumina Inc (ILMN) Q1 2019 Earnings Call Transcript

    ILMN earnings call for the period ending March 31, 2019.

  • Illumina Hits a Lull in the First Quarter
    Motley Fool23 days ago

    Illumina Hits a Lull in the First Quarter

    The gene-sequencing leader's revenue and earnings growth rates slowed down in the first quarter, but stronger growth is likely on the way.

  • This Genetics Behemoth Just Outran First-Quarter Earnings Forecasts
    Investor's Business Daily23 days ago

    This Genetics Behemoth Just Outran First-Quarter Earnings Forecasts

    Illumina and PerkinElmer earnings beat first-quarter expectations when the two reported results late Thursday. But Illumina and PerkinElmer shares stumbled in action after the close.